SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-080687
Filing Date
2024-03-28
Accepted
2024-03-28 16:27:32
Documents
5
Effectiveness Date
2024-03-28

Document Format Files

Seq Description Document Type Size
1 S-8 d819621ds8.htm S-8 40652
2 EX-5.1 d819621dex51.htm EX-5.1 9049
3 EX-23.1 d819621dex231.htm EX-23.1 1465
4 EX-FILING FEES d819621dexfilingfees.htm EX-FILING FEES 19164
5 GRAPHIC g819621g0327073308828.jpg GRAPHIC 2534
  Complete submission text file 0001193125-24-080687.txt   75069
Mailing Address 2801 CENTERVILLE ROAD 1ST FLOOR PMB #117 WILMINGTON DE 19808
Business Address 2801 CENTERVILLE ROAD 1ST FLOOR PMB #117 WILMINGTON DE 19808 877-354-3689
Eliem Therapeutics, Inc. (Filer) CIK: 0001768446 (see all company filings)

IRS No.: 832273741 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-278328 | Film No.: 24799508
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)